Pfizer's COVID-19 Vaccine Might Not Reach Local Pharmacies Due to Super-Cooling Concerns

Medicine & Technology Nov 10, 2020

The ultra-cold storage might prove to be the vaccine's biggest hurdle yet.

Moderna, Pfizer Reveal COVID-19 Vaccine Trial Blueprints

Sep 18, 2020

American drug companies Moderna and Pfizer have disclosed its secret blueprints in their respective coronavirus disease (COVID-19) vaccine trials in a move to gain the confidence of the clamoring public and scientific communities.

COVID 19: Pfizer Teams up With Gilead to Manufacture Remdesivir

Aug 07, 2020

Pharmaceutical giant Pfizer has signed a multi-year deal with Gilead Sciences Inc., to boost the production of its investigational antiviral remdesivir, a potential drug against COVID-19.

US Reached $1.95 Billion Deal With Pfizer for 100 Million Doses of Their Vaccine Candidate

Jul 23, 2020

The deal stated that the 100 million doses of coronavirus vaccine is free to Americans, although health care providers could charge for administration. The deal would also allow the federal government to acquire an additional 500 million doses of the Pfizer vaccine.

A Clinical Study Finds Pfizer's Dacomitinib Delays The Growth of Lung Cancer Cells Better Than AstraZeneca's Iressa

Jun 06, 2017

In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.

Pfizer: Chantix Does Not Increase Risks for Heart Attack and Depression

Sep 08, 2015

A new study released contradicted previous claim that the stop-smoking drug of Pfizer causes an increase risk of heart attacks and depression to users.

The Long Wait is Over: Pfizer's Pending Acquisition of Hospira Approves

Aug 26, 2015

The long wait for Pfizer over the pending acquisition for Hospira is finally over.

Pfizer Announces IBRANCE Clinical Trials Ended Early In Light of Promising News

Apr 16, 2015

In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.

FDA Issues Warning for the Quit-Smoking Drug Chantix

Mar 10, 2015

Chantix has helped many people quit smoking in the years since its release. However, on Monday the U.S. Food and Drug Administration issued a warning about the quit-smoking drug made by Pfizer Inc. According to the FDA, the drug has been associated with seizures and that some patients who drink while taking the drug may become aggressive or even black out.

Pfizer Explores Gene Therapy In Developing Treatment For Rare Diseases

Dec 09, 2014

Despite the number of mixed results in gene therapy which has had its share of setbacks, drug company giant Pfizer Inc. is pushing through with its gene therapy project. This is backed by advancement in technology and better research facilities, and for its first project, a partnership with privately-owned biotech firm Spark Therapeutics.